Pruritus
3
Companies
9
Drug Programs
2
Phase 3
0
Upcoming PDUFAs
VYNE Therapeutics Inc.
5mg Serlopitant Tablets
VYNE Therapeutics Inc.
Placebo Tablets
VYNE Therapeutics Inc.
5 mg Serlopitant Tablets
Cara Therapeutics, Inc.
Part A: Placebo
Cara Therapeutics, Inc.
difelikefalin 2.0 mg
VYNE Therapeutics Inc.
Matching Placebo Tablets
VYNE Therapeutics Inc.
Serlopitant High Dose
Yarrow Bioscience, Inc.
Serlopitant High Dose
Cara Therapeutics, Inc.
difelikefalin 0.25 mg
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| VYNE VYNE Therapeutics Inc. | 5mg Serlopitant Tablets | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Placebo Tablets | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | 5 mg Serlopitant Tablets | Phase 2 | — | — | — |
| CARA Cara Therapeutics, Inc. | Part A: Placebo | Phase 2 | — | — | — |
| CARA Cara Therapeutics, Inc. | difelikefalin 2.0 mg | Phase 2 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Matching Placebo Tablets | Phase 2 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Serlopitant High Dose | Phase 2 | — | — | — |
| YARW Yarrow Bioscience, Inc. | Serlopitant High Dose | Phase 2 | — | — | — |
| CARA Cara Therapeutics, Inc. | difelikefalin 0.25 mg | Phase 2 | — | — | — |
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.